Ulziibat Shirendeb et al. compared frontal cortex specimens of stage III and IV HD patients and control patients, and it was found that the HD patients’ specimens had increased expression of DRP1, FIS1, CypD and decreased expression of MFN1, MFN2, and OPA1 [158]. This evidence concerns the gene DNM1L and Huntington disease.